Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography–electrospray ionization-tandem mass spectrometry and pharmacokinetic application-Reference-Cited by-同舟云学术

Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography–electrospray ionization-tandem mass spectrometry and pharmacokinetic application

Published:2010-03 Issue:4 Volume:51 Page:958-964
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Zhou Qingyu,Gallo James M.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference17 articles.

1. SU11248 inhibits c-KIT and platelet-derived growth factor receptor-β in preclinical models of human small cell lung cancer;Abrams;Mol. Cancer Ther.,2003

2. Sunitinib: from rational design to clinical efficacy;Chow;J. Clin. Oncol.,2007

3. Molecular basis for sunitinib efficacy and future clinical development;Faivre;Nat. Rev. Drug Discov.,2007

4. A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period;Britten;Cancer Chemother. Pharmacol.,2008

5. A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients;Houk;Clin. Cancer Res.,2009

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromatographic and mass spectrometric analytical strategies for profiling tyrosine kinase inhibitors in biological samples;Microchemical Journal;2024-06

2. Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment;PLOS Computational Biology;2024-05-03

3. A mathematical model for the role of dopamine-D2 self-regulation in the production of ultradian rhythms;PLOS Computational Biology;2024-05-03

4. Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study;Frontiers in Pharmacology;2023-11-10

5. Magnetic solid phase extraction of Sunitinib malate in urine samples assisted with mixed hemimicelle and spectrophotometric detection;Scientific Reports;2023-02-27